Total Funding
37
7
Total FundingConvertible Note raised
Growth Score 37 in past quarter
-3 pts
Heat Score 7 in past quarter
-44 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
291509
CryptoMedix LLC is a biotechnology company that engages in the discovery, clinical development, and commercialization of a portfolio.
- Peter Brooks: Co-Founder and Chief Scientific Adviser
- Bernd Seizinger: Co-Founder, Executive Chairman, and Acting CEO
About the Company
CryptoMedix LLC is a biotechnology company that engages in the discovery, clinical development, and commercialization of a portfolio of therapeutic biologics and diagnostic agents for cancer and certain inflammatory diseases. It focuses on a set of core monoclonal antibodies (mAbs) at various stages of pre-clinical and early clinical development
that specifically target and inhibit distinct ‘cryptic’ epitopes of collagen. The company was founded in 2013 and is based in Harpswell, Maine.
